Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy

Cell Reports Medicine - Tập 4 - Trang 100919 - 2023
Steicy Sobrino1, Alessandra Magnani2,3, Michaela Semeraro4, Loredana Martignetti5, Akira Cortal5, Adeline Denis1, Chloé Couzin2,3, Capucine Picard6,7,8, Jacinta Bustamante6,9,10, Elisa Magrin2,3, Laure Joseph2, Cécile Roudaut2,3, Aurélie Gabrion2,3, Tayebeh Soheili1, Corinne Cordier11, Olivier Lortholary12, François Lefrere2,13, Frédéric Rieux-Laucat14, Jean-Laurent Casanova9,10, Sylvain Bodard15,16
1Human Lymphohematopoiesis Laboratory, Université Paris Cité, Imagine Institute, INSERM UMR 1163, Paris, France
2Biotherapy Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France
3Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, AP-HP, INSERM, Paris, France
4Clinical Investigation Center CIC 1419, Necker-Enfants Malades Hospital, GH Paris Centre, Université Paris Cité, AP-HP, Paris, France
5Clinical Bioinformatics Laboratory, Université Paris Cité, Imagine Institute, INSERM UMR 1163, Paris, France
6Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France
7Lymphocyte Activation and Susceptibility to EBV Infection Laboratory, INSERM UMR 1163, Imagine Institute, Paris, France
8Centre de Références des Déficits Immunitaires Héréditaires (CEREDIH), Necker-Enfants Malades Hospital, AP-HP, Paris, France
9Human Genetics of Infectious Diseases Laboratory, Université Paris Cité, Imagine Institute, INSERM UMR 1163, Paris, France
10St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
11Plateforme de Cytométrie en Flux, Structure Fédérative de Recherche Necker, INSERM US24-CNRS UAR3633, Paris, France
12Necker-Pasteur Center for Infectious Diseases and Tropical Medicine, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Imagine Institute, Paris, France
13Department of Adult Hematology, Necker-Enfants Malades Hospital, AP-HP, Paris, France
14Immunogenetics of Pediatric Autoimmune Diseases Laboratory, Université Paris Cité, Imagine Institute, INSERM UMR 1163, Paris, France
15Department of Adult Radiology, Necker Enfants-Malades Hospital, AP-HP, Université Paris Cité, Paris, France
16Laboratoire d’Imagerie Biomédicale, LIB, Sorbonne Université, CNRS, INSERM, Paris, France

Tài liệu tham khảo

Bousfiha, 2020, Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification, J. Clin. Immunol., 40, 66, 10.1007/s10875-020-00758-x Tangye, 2020, Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee, J. Clin. Immunol., 40, 24, 10.1007/s10875-019-00737-x Roos, 2017, Biochemical and genetic diagnosis of chronic granulomatous disease. Immunology and immune system disorders, 231 Roos, 2016, Chronic granulomatous disease, Br. Med. Bull., 118, 50, 10.1093/bmb/ldw009 van den Berg, 2009, Chronic granulomatous disease: the European experience, PLoS One, 4, e5234, 10.1371/journal.pone.0005234 Marciano, 2015, Common severe infections in chronic granulomatous disease, Clin. Infect. Dis., 60, 1176, 10.1093/cid/ciu1154 Magnani, 2014, Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease, J. Allergy Clin. Immunol., 134, 655, 10.1016/j.jaci.2014.04.014 Marciano, 2017, Inflammatory manifestations in chronic granulomatous disease, 163 van de Veerdonk, 2017, Dysfunctional processes regulating IL-1B in chronic granulomatous disease, 69–87, 69 Chiesa, 2020, Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults, Blood, 136, 1201, 10.1182/blood.2020005590 Cole, 2013, Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation, J. Allergy Clin. Immunol., 132, 1150, 10.1016/j.jaci.2013.05.031 Gennery, 2010, Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?, J. Allergy Clin. Immunol., 126, 602, 10.1016/j.jaci.2010.06.015 Martinez, 2012, Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease, J. Allergy Clin. Immunol., 129, 176, 10.1016/j.jaci.2011.10.005 Grez, 2011, Gene therapy of chronic granulomatous disease: the engraftment dilemma, Mol. Ther., 19, 28, 10.1038/mt.2010.232 Malech, 1997, Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease, Proc. Natl. Acad. Sci. USA, 94, 12133, 10.1073/pnas.94.22.12133 Ott, 2006, Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1, Nat. Med., 12, 401, 10.1038/nm1393 Stein, 2010, Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease, Nat. Med., 16, 198, 10.1038/nm.2088 Brendel, 2018, Non-clinical efficacy and safety studies on G1XCGD, a lentiviral vector for ex vivo gene therapy of X-linked chronic granulomatous disease, Hum. Gene Ther. Clin. Dev., 29, 69, 10.1089/humc.2017.245 Kohn, 2020, Lentiviral gene therapy for X-linked chronic granulomatous disease, Nat. Med., 26, 200, 10.1038/s41591-019-0735-5 Weisser, 2016, Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions, J. Allergy Clin. Immunol., 138, 219, 10.1016/j.jaci.2015.11.028 Meda Spaccamela, 2019, High levels of IL-18 and IFN-γ in chronically inflamed tissue in chronic granulomatous disease, Front. Immunol., 10, 2236, 10.3389/fimmu.2019.02236 Zonari, 2017, Efficient ex vivo engineering and expansion of highly purified human hematopoietic stem and progenitor cell populations for gene therapy, Stem Cell Rep., 8, 977, 10.1016/j.stemcr.2017.02.010 Martignetti, 2016, ROMA: representation and quantification of module activity from target expression data, Front. Genet., 7, 18, 10.3389/fgene.2016.00018 Kiselev, 2019, Challenges in unsupervised clustering of single-cell RNA-seq data, Nat. Rev. Genet., 20, 273, 10.1038/s41576-018-0088-9 Cortal, 2021, Gene signature extraction and cell identity recognition at the single-cell level with Cell-ID, Nat. Biotechnol., 39, 1095, 10.1038/s41587-021-00896-6 Velten, 2017, Human haematopoietic stem cell lineage commitment is a continuous process, Nat. Cell Biol., 19, 271, 10.1038/ncb3493 Finak, 2015, MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data, Genome Biol., 16, 278, 10.1186/s13059-015-0844-5 Liberzon, 2015, The Molecular Signatures Database (MSigDB) hallmark gene set collection, Cell Syst., 1, 417, 10.1016/j.cels.2015.12.004 Torang, 2019, An elastic-net logistic regression approach to generate classifiers and gene signatures for types of immune cells and T helper cell subsets, BMC Bioinf., 20, 433, 10.1186/s12859-019-2994-z Pietras, 2016, Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal, Nat. Cell Biol., 18, 607, 10.1038/ncb3346 Chen, 2010, Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice, J. Clin. Invest., 120, 4091, 10.1172/JCI43873 Takizawa, 2017, Pathogen-induced TLR4-TRIF innate immune signaling in hematopoietic stem cells promotes proliferation but reduces competitive fitness, Cell Stem Cell, 21, 225, 10.1016/j.stem.2017.06.013 Zhang, 2016, Sepsis induces hematopoietic stem cell exhaustion and myelosuppression through distinct contributions of TRIF and MYD88, Stem Cell Rep., 6, 940, 10.1016/j.stemcr.2016.05.002 Hirai, 2006, C/EBPbeta is required for “emergency” granulopoiesis, Nat. Immunol., 7, 732, 10.1038/ni1354 Manz, 2014, Emergency granulopoiesis, Nat. Rev. Immunol., 14, 302, 10.1038/nri3660 Montandon, 2013, Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells, Proc. Natl. Acad. Sci. USA, 110, E2199, 10.1073/pnas.1222446110 Xie, 2004, Stepwise reprogramming of B cells into macrophages, Cell, 117, 663, 10.1016/S0092-8674(04)00419-2 Audzevich, 2017, Pre/pro-B cells generate macrophage populations during homeostasis and inflammation, Proc. Natl. Acad. Sci. USA, 114, E3954, 10.1073/pnas.1616417114 Essers, 2009, IFNalpha activates dormant haematopoietic stem cells in vivo, Nature, 458, 904, 10.1038/nature07815 Matatall, 2016, Chronic infection depletes hematopoietic stem cells through stress-induced terminal differentiation, Cell Rep., 17, 2584, 10.1016/j.celrep.2016.11.031 King, 2011, Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling, Blood, 118, 1525, 10.1182/blood-2011-01-328682 Sato, 2009, Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion, Nat. Med., 15, 696, 10.1038/nm.1973 Lin, 2014, IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation, Blood, 124, 3699, 10.1182/blood-2014-01-549527 Baldridge, 2010, Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection, Nature, 465, 793, 10.1038/nature09135 Crow, 2022, The type I interferonopathies: 10 years on, Nat. Rev. Immunol., 22, 471, 10.1038/s41577-021-00633-9 Roy, 2021, Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development, Cell Rep., 36, 109698, 10.1016/j.celrep.2021.109698 Lu, 2022, Srebf1c preserves hematopoietic stem cell function and survival as a switch of mitochondrial metabolism, Stem Cell Rep., 17, 599, 10.1016/j.stemcr.2022.01.011 de Laval, 2020, C/EBPβ-Dependent epigenetic memory induces trained immunity in hematopoietic stem cells, Cell Stem Cell, 26, 793, 10.1016/j.stem.2020.03.014 Esplin, 2011, Chronic exposure to a TLR ligand injures hematopoietic stem cells, J. Immunol., 186, 5367, 10.4049/jimmunol.1003438 Davidsson, 2018, SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies, Leukemia, 32, 1106, 10.1038/s41375-018-0074-4 Thomas, 2021, Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells, Leukemia, 35, 3232, 10.1038/s41375-021-01212-6 Hoggatt, 2009, Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation, Blood, 113, 5444, 10.1182/blood-2009-01-201335 North, 2007, Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis, Nature, 447, 1007, 10.1038/nature05883 Chace, 1995, Regulation of differentiation of peritoneal B-1a (CD5+) B cells. Activated peritoneal macrophages release prostaglandin E2, which inhibits IgM secretion by peritoneal B-1a cells, J. Immunol., 154, 5630, 10.4049/jimmunol.154.11.5630 Weissmann, 1993, Prostaglandins as modulators rather than mediators of inflammation, J. Lipid Mediat., 6, 275 Goujon, 2013, Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection, Nature, 502, 559, 10.1038/nature12542 Colomer-Lluch, 2018, Restriction factors: from intrinsic viral restriction to shaping cellular immunity against HIV-1, Front. Immunol., 9, 2876, 10.3389/fimmu.2018.02876 Petrillo, 2018, Cyclosporine H overcomes innate immune restrictions to improve lentiviral transduction and gene editing in human hematopoietic stem cells, Cell Stem Cell, 23, 820, 10.1016/j.stem.2018.10.008 Jofra Hernández, 2021, Hematopoietic tumors in a mouse model of X-linked chronic granulomatous disease after lentiviral vector-mediated gene therapy, Mol. Ther., 29, 86, 10.1016/j.ymthe.2020.09.030 Klatt, 2020, Competitive sgRNA screen identifies p38 MAPK as a druggable target to improve HSPC engraftment, Cells, 9, 2194, 10.3390/cells9102194 Vanderver, 2020, Janus kinase inhibition in the aicardi-goutières syndrome, N. Engl. J. Med., 383, 986, 10.1056/NEJMc2001362 Sanchez, 2018, JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies, J. Clin. Invest., 128, 3041, 10.1172/JCI98814 Forbes, 2018, Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations, J. Allergy Clin. Immunol., 142, 1665, 10.1016/j.jaci.2018.07.020 Schuettpelz, 2014, G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling, Leukemia, 28, 1851, 10.1038/leu.2014.68 Walter, 2015, Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells, Nature, 520, 549, 10.1038/nature14131 Schmidt, 2001, Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples, Hum. Gene Ther., 12, 743, 10.1089/104303401750148649 Afzal, 2017, GENE-IS: time-efficient and accurate analysis of viral integration events in large-scale gene therapy data, Mol. Ther. Nucleic Acids, 6, 133, 10.1016/j.omtn.2016.12.001 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, 102, 15545, 10.1073/pnas.0506580102 Lun, 2016, Pooling across cells to normalize single-cell RNA sequencing data with many zero counts, Genome Biol., 17, 75, 10.1186/s13059-016-0947-7 Couckuyt, 2022, Challenges in translational machine learning, Hum. Genet., 141, 1451, 10.1007/s00439-022-02439-8 Zou, 2005, Regularization and variable selection via the elastic net, J. Roy. Stat. Soc. B, 67, 301, 10.1111/j.1467-9868.2005.00503.x